<?xml version="1.0" encoding="UTF-8"?>
<boxed-text id="pmed.1003092.box002" position="float" orientation="portrait">
 <sec id="sec005">
  <title>Box 1. The concept of reliance in the regulation of medicines</title>
  <sec id="sec006">
   <title>Definition of regulatory reliance</title>
   <p>Reliance is defined by WHO as “an act whereby a regulatory authority in one jurisdiction may take into account or give significant weight to work performed by another regulator, or other trusted institution, in reaching its own decision” [
    <xref rid="pmed.1003092.ref019" ref-type="bibr">19</xref>].
   </p>
  </sec>
  <sec id="sec007">
   <title>How regulatory reliance works</title>
   <p>In practice, reliance can take many forms, such as establishing a recognition protocol by which the decisions of trusted regulatory authorities (such as WHO’s Prequalification Programme, the US FDA, or the EU’s medicines assessment and licensing system) are routinely accepted or developing an abridged review process for products already approved by those institutions [
    <xref rid="pmed.1003092.ref020" ref-type="bibr">20</xref>,
    <xref rid="pmed.1003092.ref021" ref-type="bibr">21</xref>].
   </p>
  </sec>
  <sec id="sec008">
   <title>Best practices for regulatory reliance</title>
   <p>Currently, WHO is developing Good Registration Practices guidelines, including a component on Good Reliance Practices to aid regulators who are seeking to implement reliance models.</p>
  </sec>
 </sec>
</boxed-text>
